Viability of a Serum Infliximab Concentration-Detecting Reagent as a Qualitative Assay for an Infliximab Biosimilar

Inagaki, T; Isesaki, T; Kawana, K; Funakoshi, R

Inagaki, T (corresponding author), Tesshokai Kameda Med Ctr, Dept Pharm, 929 Higashi Cho, Kamogawa, Chiba 2968602, Japan.

BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021; 44 (9): 1272

Abstract

The efficacy of infliximab in treating rheumatoid arthritis depends on its serum trough concentration, which must be maintained at a minimum of 1 mu g......

Full Text Link